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Protect Group A Streptococcus from Xenophagic Killing
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Division of Infectious Diseases, Boston Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Group A Streptococcus (Streptococcus pyogenes or GAS) causes pharyngitis, severe invasive infections, and the post-
infectious syndromes of glomerulonephritis and rheumatic fever. GAS can be internalized and killed by epithelial cells in
vitro, a process that may contribute to local innate defense against pharyngeal infection. Secretion of the pore-forming
toxin streptolysin O (SLO) by GAS has been reported to stimulate targeted autophagy (xenophagy) upon internalization of
the bacteria by epithelial cells. Whereas this process was associated with killing of GAS in HeLa cells, studies in human
keratinocytes found SLO production enhanced intracellular survival. To reconcile these conflicting observations, we now
report in-depth investigation of xenophagy in response to GAS infection of human oropharyngeal keratinocytes, the
predominant cell type of the pharyngeal epithelium. We found that SLO expression was associated with prolonged
intracellular survival; unexpectedly, expression of the co-toxin NADase was required for this effect. Enhanced intracellular
survival was lost upon deletion of NADase or inactivation of its enzymatic activity. Shortly after internalization of GAS by
keratinocytes, SLO-mediated damage to the bacteria-containing vacuole resulted in exposure to the cytosol, ubiquitination
of GAS and/or associated vacuolar membrane remnants, and engulfment of GAS in LC3-positive vacuoles. We also found
that production of streptolysin S could mediate targeting of GAS to autophagosomes in the absence of SLO, a process
accompanied by galectin 8 binding to damaged GAS-containing endosomes. Maturation of GAS-containing autophago-
some-like vacuoles to degradative autolysosomes was prevented by SLO pore-formation and by SLO-mediated
translocation of enzymatically active NADase into the keratinocyte cytosol. We conclude that SLO stimulates xenophagy
in pharyngeal keratinocytes, but the coordinated action of SLO and NADase prevent maturation of GAS-containing
autophagosomes, thereby prolonging GAS intracellular survival. This novel activity of NADase to block autophagic killing of
GAS in pharyngeal cells may contribute to pharyngitis treatment failure, relapse, and chronic carriage.
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Introduction
The human-specific pathogen Streptococcus pyogenes (Group A
Streptococcus or GAS) is responsible for common localized infections
such as pharyngitis and impetigo as well as less common, but
potentially life threatening, conditions including necrotizing
fasciitis and streptococcal toxic shock [1]. The pharynx is thought
to be the site of initial colonization not only for pharyngitis, but
also in most cases of invasive infection. In addition, persistence or
recrudescence of pharyngeal colonization has been associated with
treatment failures and with relapses after completion of antibiotic
therapy for streptococcal pharyngitis [2,3]. In the 1990s, studies
from several laboratories demonstrated that GAS can enter
epithelial cells in vitro [4,5,6,7,8,9]. It has been suggested that
survival of the bacteria within pharyngeal or tonsillar epithelial
cells in vivo may contribute to persistence, as intracellular
organisms are protected from many antimicrobial agents and host
immune effectors such as complement and antibodies. In support
of this view, intracellular GAS have been identified by microscopy
and isolated in cultures of surgical specimens of human tonsils,
even after treatment of the excised tissue with antibiotics to kill
extracellular bacteria [10].
In vitro studies suggest that GAS do not proliferate within
epithelial cells [4,9,11]; however, viable bacteria have been
recovered from infected cell lines in vitro and from clinical
specimens of excised tonsillar tissue days after antibiotic treatment,
results consistent with prolonged survival of a subpopulation of
GAS in an intracellular niche [9,10,12]. Eventual emergence of
viable organisms into the extracellular milieu could serve as a
source for relapsing or recurrent infection or transmission to
others. The concept of pharyngeal epithelial cells as a possible
sanctuary site for GAS persistence has stimulated interest in
characterizing the cell biology of internalization and intracellular
trafficking of GAS.
Studies from our laboratory and by others have implicated the
secreted GAS toxin streptolysin O (SLO) as a critical factor
modulating the interaction of GAS with epithelial cells in vitro
[13,14,15,16,17]. SLO is a member of the cholesterol-dependent
cytolysins (CDCs), a large family of related toxins produced by
many species of gram-positive bacteria. CDCs bind to cholesterol-
containing membranes where they oligomerize and insert into the
lipid bilayer to form large pores [18,19]. Certain CDCs have
important biological functions beyond simply cytolytic activity;
examples include escape of Listeria monocytogenes from the phagosome
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into the cytosol of macrophages mediated by listeriolysin O and
Toll-like receptor signaling by pneumolysin, a product of S.
pneumoniae, and by other CDCs [20,21,22]. Nakagawa et al.
discovered that SLO production by GAS stimulated association of
internalized bacteria with autophagosome-like vacuoles in HeLa
cells and promoted killing of the internalized bacteria [16]. In a
follow up study, Sakurai et al. reported more efficient intracellular
killing of wild-type GAS compared to a SLO-negative mutant after
internalization into HeLa cells [17]. By contrast, Hakansson et al.
found significantly greater intracellular survival of SLO-producing
GAS in human oropharyngeal keratinocytes in vitro compared to an
isogenic SLO-negative mutant [14]. The apparently contradictory
results of these studies on the effect of SLO on intracellular survival
of GAS might reflect differences in GAS strains, differences in
epithelial cell lines, and/or differences in experimental conditions
used in previous studies.
In this study, we investigated in greater depth the role of SLO in
inducing targeted anti-bacterial autophagy (xenophagy) in re-
sponse to GAS infection of human oropharyngeal keratinocytes,
cells representative of the usual site of colonization and infection
with GAS. We found that xenophagy was stimulated by SLO, but
also by streptolysin S (SLS); however, functional maturation of
GAS-containing autophagosomes was inhibited by the pore-
forming activity of SLO and by translocation of the co-toxin,
NAD-glycohydrolase (NADase). The coordinated actions of SLO
and NADase prolonged GAS intracellular survival by preventing
effective trafficking of GAS to degradative autolysosomes.
Results
Streptolysin O expression is associated with enhanced
intracellular survival of GAS in oropharyngeal
keratinocytes
Alternative experimental models have yielded conflicting results
with respect to the effect of SLO on intracellular survival of GAS
after internalization by epithelial cells in vitro. To reconcile these
earlier observations and to assess more thoroughly the long-term
outcome of GAS internalized within pharyngeal epithelial cells, we
monitored the intracellular survival of GAS in OKP7 human
oropharyngeal keratinocytes over a 24-hour period. Intracellular
CFU were assessed by quantitative culture at various time points
post-infection and were expressed as a percentage of the
intracellular CFU recovered at 2 h. The mean number of
intracellular bacteria recovered at 2 h was greater for the SLO-
negative mutant strain 188SLO- (3.36104 CFU/monolayer) than
for the parental strain 188 (3.16103 CFU/monolayer), as reported
previously [14,15].
Comparison of the mean intracellular survival of GAS strain
188 and its isogenic SLO-negative mutant, 188SLO-, revealed
67% survival of parent strain 188 at 6 h, 22% at 12 h, and 14%
survival at 24 h. By contrast, intracellular survival of 188SLO- was
33% at 6 h, 8% at 12 h, and only 1% at 24 h (Figure 1A). Thus,
production of SLO was associated with a 14-fold advantage in
intracellular survival 24 hours after infection. To confirm that the
improved survival phenotype required SLO production, we
performed similar experiments with strain 188SLO-(piSLO) in
which the deletion of slo is partially complemented in trans by
expression of slo from a plasmid [15]. SLO hemolytic activity of
188SLO-(piSLO) is approximately 10% of that associated with
strain 188 upon IPTG induction of SLO expression [15]. Partial
restoration of SLO production in 188SLO-(piSLO) resulted in a 4-
fold increase in intracellular survival at 24 h relative to that of
188SLO- containing the vector alone (188SLO-(pSIV)) (Figure 1B).
We observed a similar trend in enhanced intracellular survival
associated with SLO production for the M type 6 strain JRS4 used
in the studies of Nakagawa et al. and Sakurai et al. [16,17]:
intracellular survival of wild-type JRS4 at 24 h was more than 5-
fold higher than that of JRS4SLO- (Figure 1C). We conclude from
these results that SLO production enhances GAS survival in
human oropharyngeal keratinocytes, a cell type representative of
the local environment occupied by GAS during human infection.
In striking contrast, similar experiments in HeLa cells revealed
more efficient killing of the SLO-producing parent strain 188
compared to its SLO-negative mutant (Supporting Information,
Figure S1A). However, SLO-producing GAS were markedly more
cytotoxic to HeLa cells, so it is likely that the low recovery of viable
intracellular SLO-producing GAS reflects loss of HeLa cell
integrity and exposure of internalized GAS to antibiotic killing
(Figure S1B,C). Thus, the effect of SLO on GAS intracellular
survival depends on epithelial cell type: SLO production was
associated with reduced survival in HeLa cervical carcinoma cells,
but increased survival in oropharyngeal keratinocytes.
SLO is not essential for GAS-induced autophagy. In
HeLa cells, secretion of SLO stimulates the formation of
autophagosome-like vacuoles that surround intracellular GAS
and appear to mediate bacterial killing, whereas GAS-associated
autophagosomes were not observed in cells infected with an SLO-
deficient strain [16,17]. In light of our apparently contradictory
finding that SLO production is associated with GAS resistance to
intracellular killing in oropharyngeal keratinocytes, we investigated
the induction of autophagy/xenophagy by GAS in keratinocytes
expressing EGFP-LC3, a marker of the autophagosomal mem-
brane. Unexpectedly, we observed LC3-positive vacuoles sur-
rounding intracellular GAS not only in cells infected with parent
strain 188 but also in cells harboring the SLO-deficient strain
188SLO- (Figure 2A). Electron microscopy confirmed these
observations: strains 188 and 188SLO- were localized to double
or multiple membrane-bound structures that also contained
cytosolic material (Figure 2B). That both GAS strains were
associated with autophagosome-like compartments indicated that
SLO is not required for GAS to induce xenophagy in oropharyn-
geal keratinocytes. A similar pattern of co-localization was
Author Summary
Group A Streptococcus (Streptococcus pyogenes or GAS) is
the agent of streptococcal pharyngitis (strep throat),
invasive infections such as necrotizing fasciitis and
streptococcal toxic shock, and post-infectious complica-
tions including rheumatic heart disease. Epithelial cells
internalize and kill GAS in vitro and may contribute to local
innate immune defense in the human pharynx. We now
find that production of the secreted pore-forming toxin
streptolysin O (SLO) triggered targeted autophagy (termed
xenophagy) of GAS in human oropharyngeal keratinocytes,
but also enhanced GAS intracellular survival. Increased
GAS survival was dependent both on pore-formation by
SLO and on SLO-mediated translocation of an enzymati-
cally active co-toxin, NAD-glycohydrolase, into the kerati-
nocyte cytosol. The survival-enhancing effect of both
toxins was associated with inhibition of lysosomal fusion
with GAS-containing autophagosomes to form functional
degradative autolysosomes. These findings reveal a novel
coordinated role of two streptococcal toxins in protecting
GAS from xenophagic killing and enhancing intracellular
survival. Prolonged GAS intracellular survival may contrib-
ute to pharyngitis treatment failure, relapse, and chronic
carriage.
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observed for cells infected with GAS strain JRS4 or JRS4SLO-:
both strains were found in LC3-positive compartments (Figure
S2A). By contrast, in HeLa cells, association of intracellular GAS
with EGFP-LC3 was dependent on SLO, as 188SLO- did not
associate with autophagosomes, a result in agreement with
previous studies (Figure S2B) [16,17]. Thus, in oropharyngeal
keratinocytes, internalization of GAS is associated with induction
of xenophagy, whether or not the internalized strain produces
SLO.
For strain 188, 40% of intracellular bacteria were associated
with LC3 at 1 h post-infection, and by 3 h, 85% were in LC3-
positive compartments. Association of 188SLO- with LC3 was
initially higher, with 72% of bacteria in autophagosomes at 1 h,
and by 3 h, 86% were associated with LC3 (Figure 2A,B).
Xenophagy can be induced by SLO or by streptolysin S,
and induction of xenophagy does not correlate with the
efficiency of intracellular killing of GAS. Induction of
xenophagy in response to intracellular bacterial pathogens is
commonly associated with damage to the bacterial vacuole
membrane by products of the invading organism. Accordingly,
we speculated that SLS, another pore-forming toxin produced by
GAS, might be responsible for stimulating xenophagy in
oropharyngeal cells infected with SLO-deficient GAS. To
investigate this hypothesis, we infected oropharyngeal keratino-
cytes expressing EGFP-LC3 with the double mutant strain
188SLO-SLS- that expresses neither SLO nor SLS, or with
188SLS-, which still produces SLO. 188SLS- associated with LC3-
positive compartments to the same extent as 188 (89% of
intracellular bacteria at 3 h), but the double mutant 188SLO-
SLS- was never found within autophagosome-like compartments
by fluorescence microscopy or electron microscopic analysis
(Figure 2A,B). Furthermore, analysis of autophagy induction by
Figure 1. SLO and NADase promote intracellular survival of GAS in oropharyngeal keratinocytes. A. Intracellular survival of GAS strains
188, 188SLO- (SLO-), and 188NADase- (NADase-). Intracellular CFU were quantified at 2 h, 4 h, 6 h, 8 h, and 24 h, and intracellular survival was
calculated as the percent viable CFU compared to 2 h. B. Intracellular survival of GAS strain 188SLO- that was partially complemented from plasmid
piSLO (SLO-(piSLO)), strain 188 and 188SLO- that contained the empty complementation vector, 188(pSIV4) and SLO-(pSIV4), respectively. C.
Intracellular survival of GAS strain JRS4, JRS4SLO- (SLO-), and JRS4NADase- (NADase-). Experiments were performed in triplicate and values represent
the mean of three independent experiments 6 SD. *, P,0.001.
doi:10.1371/journal.ppat.1003394.g001
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Western blot revealed that exposure of OKP7 cells to GAS strains
expressing SLO (and to a lesser extent, SLS), or to recombinant
SLO correlated with a clear increase in the relative abundance of
LC3-II, the form of LC3 associated with autophagosomes,
whereas relative LC3-II abundance in cells exposed to 188SLO-
SLS- was indistinguishable from that in uninfected cells (Figure
S2C). These results indicate that production of either SLO or SLS
is sufficient to trigger a xenophagic response to GAS in
oropharyngeal keratinocytes.
The fact that a GAS strain deficient in both SLO and SLS failed
to induce xenophagy provided an opportunity to investigate
whether xenophagy is associated with increased intracellular
killing of GAS. Intracellular survival rates of 188 and 188SLS-
were similar, and survival of both strains was significantly greater
Figure 2. Xenophagy in oropharyngeal keratinocytes can be stimulated by SLO or SLS and is not associated with killing of
intracellular GAS. A. Confocal microscopy of the association between EGFP-LC3 and GAS strain 188, 188SLO- (SLO-), 188SLS- (SLS-), or 188SLO-SLS-
(SLO-SLS-). Immunofluorescent staining distinguished intracellular (Alexa-568, red) from extracellular (Alexa-568 and Alexa-660, red and blue,
respectively) GAS. Scale bar = 10 mm. The percent of intracellular GAS that were associated with EGFP-LC3 at 3 h post-infection is shown for each
strain. B. Electron microscopy of GAS strains 188, 188SLO-, and 188SLO-SLS- at 3 h post-infection. Arrowheads indicate the presence of double or
multiple membranes (188 and 188SLO-) or single membranes (188SLO-SLS-) partially or completely surrounding bacteria. Vacuolar compartments
associated with 188 and 188SLO- also contain cytosolic material. C. Intracellular survival of GAS strains 188, 188SLO-, 188SLS-, and 188SLO-SLS-. *,
P,0.05. D. Intracellular survival of 188 or 188SLO- in the presence or absence of Beclin1 knockdown.
doi:10.1371/journal.ppat.1003394.g002
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than that of 188SLO- or 188SLO-SLS- (Figure 2C). We observed
approximately 2-fold greater survival of 188SLO-SLS- compared
to 188SLO-. The fact that 188SLO-SLS- fails to induce
xenophagy, yet is killed more efficiently than 188 or 188SLS-
(that do induce xenophagy) indicates that xenophagy is not a
required step in targeting intracellular GAS for efficient killing.
We also assessed intracellular survival of GAS in keratinocytes
treated with siRNA targeted to becn1, which encodes Beclin 1, a
component of the class III phosphatidylinositol-3-kinase complex
that is required for autophagy (Figure S3) [23,24]. Knock-down
of Beclin 1 had no effect on intracellular survival of 188 or
188SLO- (Figure 2D). Taken together, these data indicate that
induction of xenophagy is not required for efficient killing of GAS
that are deficient in SLO and SLS, whereas SLO-producing GAS
exhibit enhanced intracellular survival despite inducing xeno-
phagy.
SLO-mediated translocation of NADase into
keratinocytes protects GAS from intracellular
killing. SLO is expressed from an operon that also encodes
NADase and its intracellular inhibitor, Immunity Factor for
Streptococcus pyogenes NADase (IFS) [25,26]. SLO and NADase are
functionally linked in that SLO is required for the translocation of
NADase across cholesterol-containing membranes [27,28]. Since
SLO-negative strains of GAS are unable to translocate NADase,
the reduced intracellular survival of such strains could be due to
the absence of SLO or to failure to translocate NADase into
keratinocytes, or both. To specifically address the potential role of
NADase, we tested intracellular survival of strain 188NADase-, an
isogenic mutant that produces SLO, but not NADase [27].
Deletion of NADase was associated with an increase in bacterial
uptake: the mean number of intracellular GAS was
8.76103 CFU/monolayer at 2 h for strain 188NADase- com-
pared to 3.16103 CFU/monolayer for strain 188, in agreement
with previously published observations [14,27]. Intracellular
survival of the NADase-negative strain was reduced by approx-
imately 20-fold compared to parent strain 188 (Figures 1A and
3A). NADase expression also enhanced intracellular survival of
GAS strain JRS4 (Figure 1C).
Translocation of NADase into keratinocytes from extracellular
GAS has been shown to result in depletion of cellular NAD+ and
ATP [29]. To test whether NAD-glycohydrolase activity of the
translocated protein is responsible for its protective effect on GAS
intracellular survival, we generated mutant strain 188NADa-
se(G330D), a derivative of 188 in which the chromosomal nga
locus harbors a point mutation coding for amino acid substitution
G330D in NADase. This mutation has been associated with
enzymatically inactive NADase in clinical isolates of GAS and in a
deliberately constructed mutant [30,31]. Measurement of the
NAD-glycohydrolase activity of culture supernatants and western
blotting using an anti-NADase antibody confirmed that 188NA-
Dase(G330D) secreted similar amounts of NADase protein as
parent strain 188, but that the protein was enzymatically inactive
(Figure 3B,C). Comparison of the intracellular survival of 188 and
188NADase(G330D) in keratinocytes revealed similarly poor
survival of 188NADase(G330D) as 188NADase-, indicating that
NAD-glycohydrolase activity is required for NADase to promote
GAS intracellular survival (Figure 3A).
As an alternative approach to investigating the role of NADase in
enhancing GAS intracellular survival, we used the NADase
inhibitor IFS to block the enzymatic activity of NADase produced
by parent strain 188. Ordinarily, IFS is produced within the
bacterial cell where it acts as an intracellular antitoxin, binding
NADase and inhibiting its enzymatic activity until NADase is
secreted [25,26]. We reasoned that IFS also could be used as an
inhibitor of enzymatic activity after NADase had been secreted from
the bacterial cell. For this purpose, we expressed FLAG-tagged IFS
preceded by an N-terminal signal sequence from the streptococcal
expression vector pDL278 in GAS strain 188. This strain,
188(pSEC-IFS), secretes IFS constitutively, the result of which is
the complete inhibition of NADase activity in culture supernatants
despite the production of NADase protein in amounts similar to
strain 188 (Figure S4). We tested 188(pSEC-IFS) in intracellular
survival assays together with 188 and 188NADase- that contained
empty expression vector, pDL278. The intracellular survival of
188(pDL278) and 188NADase-(pDL278) was as expected: deletion
of NADase resulted in a 30-fold decrease in intracellular survival.
Figure 3. Expression of active NADase plays a central role in the intracellular survival of GAS in oropharyngeal keratinocytes. A.
Intracellular survival of GAS strains 188, 188NADase-, and 188NADase(G330D). Deletion of the gene encoding NADase or inactivation of NADase by
the amino acid substitution G330D resulted in a 20- to 40-fold reduction in intracellular survival compared to parent strain 188. *, P,0.001. NADase
western blot (B) and activity measurements (C) of culture supernatants from GAS strains 188, 188NADase-, and 188NADase(G330D).
doi:10.1371/journal.ppat.1003394.g003
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The intracellular survival of 188(pSEC-IFS) was also significantly
lower (15-fold) than that of 188, supporting the hypothesis that
inactivation of secreted NADase promoted the killing of intracel-
lular GAS (Figure S4).
Pore-formation by SLO promotes cytosolic exposure and
survival of intracellular GAS. The finding that NADase plays
a major role in GAS intracellular survival raised the possibility that
the importance of SLO in GAS survival might be limited to its
ability to translocate NADase into the host cell. In order to test
whether the pore-forming activity of SLO also contributes to GAS
intracellular survival independently of NADase translocation, we
took advantage of the observation of Magassa et al. that the pore-
forming and NADase-translocating activities of SLO are separa-
ble: these authors described an amino acid substitution in SLO,
Y255A, that prevented pore-formation and cytolytic activity, but
preserved NADase translocation [32]. We introduced this
substitution into the chromosomal slo locus in strain 188 to
generate 188SLO(Y255A). Measurement of the hemolytic titer
and SLO production from the culture supernatant of
188SLO(Y255A) confirmed that the mutant strain had lost the
capacity to lyse erythrocytes but still produced a similar amount of
SLO protein as the parent strain (Figure 4B).
Next, we investigated NADase translocation by the
SLO(Y255A) variant. NADase translocation can be measured by
determining the NADase activity in the cytosol of cells exposed to
extracellular GAS. To do this, we introduced the SLO(Y255A)
substitution into strain 950771 (referred to hereafter as 771), the
encapsulated wild-type strain from which strain 188 was derived
by inactivation of the hyaluronic acid capsule biosynthetic locus
[33]. Capsule greatly reduces internalization of GAS, and well-
encapsulated strains such as 771 allow accurate measurement of
NADase translocation from outside the cell, rather than produc-
tion of NADase by intracellular GAS [9,27]. Keratinocytes were
incubated for 1.5 h with 771, 771SLO-, 771SLO(Y255A), or
771NADase- in the presence of cytochalasin D to further reduce
bacterial internalization, and NADase activity in the extracellular
medium and the keratinocyte cytosol was measured. NADase
production and secretion by 771, 771SLO-, and 771SLO(Y255A)
was similar, as demonstrated by the NADase activities from
culture supernatants (Figure 4C). Strains 771 and
771SLO(Y255A) translocated similar amounts of NADase activity
into the cytosol of GAS-exposed keratinocytes, whereas intracel-
lular NADase activity due to 771SLO- was greatly reduced and
none was detected in the cells exposed to 771NADase- (Figure 4C).
These data demonstrate that 771SLO(Y255A) and, by inference,
188SLO(Y255A) are defective in SLO pore-formation but not in
NADase translocation.
In considering the possible importance of SLO pore-formation
in the intracellular survival of GAS, we first investigated whether
SLO produced by intracellular GAS damaged the membrane of
the bacteria-containing vacuole. Nakagawa et al. proposed that
shortly after invasion of epithelial cells, GAS escape early
endosomes and enter the cytosol in a SLO-dependent manner
[16]. To test directly whether internalized GAS disrupt the
integrity of the endosomal membrane, we investigated whether
GAS become ubiquitinated after internalization. Consistent with
the model of SLO-mediated escape into the host cytosol, we found
that most intracellular organisms of strain 188 co-localized with
ubiquitin within 30 min of exposure to keratinocytes (.95%). On
the other hand, fewer than 5% of intracellular 188SLO- bacteria
were associated with ubiquitin (Figure 4A). We speculated that the
ubiquitination of 188SLO-, albeit at a much-reduced level
compared to 188, might be explained by vacuolar membrane
damage and consequent cytosolic exposure due to the production
of SLS. Indeed, intracellular 188SLO-SLS- bacteria were never
observed to be associated with ubiquitin (not shown). Strain
188SLS-, which produces wild-type amounts of SLO, behaved
similarly to the parental strain with respect to ubiquitin-binding
(90% at 30 min). As with parent strain 188, intracellular
188NADase- bacteria also became ubiquitinated, a result that
implies that NADase is not required for the vacuolar membrane
damage that exposes internalized GAS to the host cell cytosol. The
pattern of ubiquitination of intracellular organisms of the SLO-
non-pore-forming, but NADase translocation-competent
188SLO(Y255A) was similar to 188SLO-, i.e., only occasional
bacteria were associated with ubiquitin (Figure 4A). This
observation indicated that pore-formation is critical to the ability
of SLO to mediate exposure of internalized GAS to keratinocyte
cytosol.
To address the specific involvement of pore formation by SLO
in the intracellular survival of GAS, we next compared the
intracellular survival of the SLO-non-pore-forming mutant
188SLO(Y255A) with that of parent strain 188 and 188SLO-.
The intracellular survival of 188SLO(Y255A) was reduced to a
similar extent as 188SLO-, and was reduced approximately 14-
fold compared to 188 (Figure 4D), results that support a specific
role of SLO-mediated pore formation in evasion of GAS killing by
oropharyngeal keratinocytes.
SLS mediates xenophagic recognition of GAS via galectin
8, in a ubiquitin-independent manner. In light of our finding
that wild-type GAS are exposed to the cytosol through SLO
poration of endosomes, it is likely that these bacteria are targeted
to autophagy through the well-characterized ubiquitin-NDP52/
p62 pathway (for reviews, see [34,35]). We next sought to
understand how, in the absence of SLO-mediated disruption of
endosome integrity (and subsequent ubiquitination of liberated
GAS), SLS could trigger a xenophagic response to GAS. SLS, like
SLO, exhibits hemolytic activity in vitro, but does not produce large
pores that can be visualized by electron microscopy [36]. It has
recently been shown that the cytosolic exposure of glycans
normally localized to the interior face of vesicular membranes
can result in binding of the cytosolic lectin, galectin 8. By
recruiting NDP52, bound galectin 8 targets damaged vesicles for
intracellular trafficking to autophagosomes in a ubiquitin-inde-
pendent manner [37]. This alternative pathway was shown to
mediate an autophagic response to membrane-damaging intracel-
lular pathogens such as Salmonella, Listeria, and Shigella. We
therefore investigated whether SLS-producing GAS stimulated
accumulation of galectin 8, even in the absence of SLO
production. Both 188 and 188SLO- associated with galectin 8
within 30 min of uptake by OKP7 cells (83% and 56% of
intracellular bacteria, respectively), whereas 188SLO-SLS- was
never found to be associated with galectin 8 (Figure 4E). These
data support a model in which SLO-deficient GAS damage the
integrity of the endosomal vacuole through the membrane-
damaging effect of SLS and thus induce the autophagic response
in the absence of ubiquitination (Figure 2A). SLO-producing GAS
cause sufficient damage to fully expose the bacteria to the cytosol
and recruit the ubiquitin pathway. The SLO-SLS- mutant cannot
damage endosomes, since it lacks both pore-forming toxins, and
does not result in galectin 8 recognition, ubiquitin binding, or
trafficking of the bacteria to autophagosomes.
SLO and NADase inhibit maturation of GAS-containing
autophagosomes. The data presented above suggest that
optimal GAS survival within human oropharyngeal cells depends
on production of both SLO and its co-toxin, NADase. However,
these results did not address the mechanism by which toxin
production inhibits intracellular killing. A previous study from our
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group showed that SLO-deficient GAS rapidly co-localized with
lysosomal markers after internalization by keratinocytes, whereas
SLO-producing GAS did not [14]. Since results of the current
investigation showed that both parent strain 188 and SLO- and
NADase-deficient GAS are contained within autophagosome-like
vacuoles, we reasoned that the differential survival of these strains
might reflect the effects of SLO and NADase on the functional
maturation of GAS-containing autophagosomes rather than
simply induction of xenophagy per se. Maturation of autophago-
somes into degradative autolysosomes occurs by fusion with
lysosomes, which can be detected in vitro by co-localization of LC3
with the lysosomal marker LAMP-1. We therefore investigated the
temporal association of LAMP-1 with LC3-positive vacuoles
containing GAS strains 188, 188SLO-, or 188NADase-. All three
GAS strains associated with LC3 shortly after internalization by
the host cell (Figure 5A). However, there was a marked difference
in the rate of lysosomal fusion: in the case of parent strain 188,
21% of LC3-associated GAS were co-localized with LAMP-1 after
1 h. At 3 h, 28% were co-localized, and by 6 h post-infection,
44% of autophagosomes containing 188 had fused with lysosomes
(Figure 5A,B). In contrast, 81% of LC3-associated 188SLO- GAS
co-localized with LAMP-1 at 1 h post infection, 72% at 3 h post-
infection, and 75% at 6 h (Figure 5A,B). LAMP-1 was also more
rapidly associated with autophagosomes harboring 188NADase-
compared to parent strain 188, although less so than the SLO-
mutant: 27% of autophagosomes containing 188NADase- were
positive for LAMP-1 at 1 h post-infection, 64% at 3 h, and 82% at
6 h (Figure 5A,B). We observed a similar pattern for the
intracellular trafficking of GAS strains JRS4, JRS4SLO-, and
JRS4NADase-. That is, JRS4SLO- and JRS4NADase- rapidly
associated with both LC3 and LAMP-1, whereas the co-
localization of LC3-positive compartments containing parent
strain JRS4 was delayed (not shown). Taken together, these data
indicate that the co-expression of SLO and NADase by GAS
inhibits maturation of GAS-containing autophagosomes into
degradative autolysosomes, and that this delay is associated with
prolonged bacterial survival in infected keratinocytes.
Discussion
The epithelial surface of the human oropharynx represents the
primary environmental niche for GAS. The bacteria are adapted
to survive in this anatomic site, and, in general, the human host is
able to contain GAS infection as localized pharyngitis or
asymptomatic carriage. In part, GAS proliferation and spread
may be controlled by ingestion and killing of the organisms by
oropharyngeal epithelial cells: in vitro assays have demonstrated
uptake of GAS by oropharyngeal keratinocytes [9,15,38]. These
studies have concluded that internalized GAS fail to proliferate
within keratinocytes and the number of viable intracellular
bacteria declines over time. However, some authors have
emphasized that a fraction of internalized GAS may survive
intracellularly for days, potentially representing a source for
relapsing or recurrent infection or persistent carriage despite
antibiotic treatment [10,12].
Nakagawa et al. proposed that GAS are not killed by endosomal-
lysosomal fusion after entry into epithelial cells, but rather that
internalized bacteria escape from the endocytic vacuole into the
cytosol where they are captured and degraded by autophagy in a
process that depends on SLO [16]. They found that SLO-deficient
GAS failed to escape from early endosomes and survived better
within HeLa cells than did the SLO-producing parent strain
[16,17]. By contrast, our group reported that SLO production was
associated with enhanced GAS survival in oropharyngeal kerati-
nocytes, while SLO-deficient organisms were efficiently killed in a
cellular compartment with features of lysosomes including
localized immunostaining for LAMP-1 and marked vacuolar
acidification [14].
In the present investigation, we examined in greater detail the
effects of SLO on intracellular trafficking and long-term survival of
GAS in oropharyngeal keratinocytes. We confirmed that produc-
tion of SLO was associated with a striking increase in intracellular
survival 24 hours after initial infection. This effect was not strain-
specific as a similar pattern was observed in two independent GAS
strains in comparison with their respective SLO-deficient mutants.
We also confirmed that internalized GAS were associated with
LC3, consistent with their containment within autophagosomes.
Electron microscopy revealed that GAS resided in double
membrane-bound structures that also contained cytosolic material,
consistent with GAS-containing autophagosome-like structures
observed in other epithelial cells [16]. Unexpectedly, SLO-
deficient strains also co-localized with LC3, whereas a double
mutant deficient in both SLO and SLS did not. We found that in
the absence of SLO, SLS production caused sufficient endosomal
membrane damage for recognition by galectin 8 and subsequent
ubiquitin-independent targeting to autophagosomes. Thus, at least
two pathways exist for GAS to autophagy, and either cytolytic
toxin can damage the endocytic vacuole sufficiently to induce a
xenophagic response that targets the hemolysin-producing bacte-
ria. These patterns of cellular response are similar to those
observed in cells infected with other bacteria that damage the
endocytic or phagocytic vacuole by production of a pore-forming
toxin, e.g., listeriolysin O of Listeria monocytogenes or the type three
secretion system of Salmonella Typhimurium [37,39,40,41].
For GAS, induction of targeted autophagy per se was not
correlated with effective killing of intracellular bacteria: SLO-
positive GAS induced xenophagy and survived well, whereas
SLO-negative (but SLS-positive) GAS also induced xenophagy,
Figure 4. SLO, SLS, and NADase affect xenophagy and GAS intracellular survival. A. Confocal microscopy demonstrating the association
between ubiquitin (green) and intracellular GAS (red) at 30 min post-infection in keratinocytes infected with GAS strain 188, 188SLO-, 188NADase-, or
188SLO(Y255A). Extracellular GAS were stained blue and red for identification as described in Figure 2. Scale bar = 10 mm. The percentage of
intracellular GAS that were associated with ubiquitin is indicated for each strain, based on quantification of at least 100 bacteria in three independent
experiments. B. Hemolytic activity of culture supernatants of GAS strain 188, 188SLO-, and 188SLO(Y255A). The amino acid substitution Y255A in SLO
abrogates the ability of SLO to porate the host cell membrane, demonstrated by the failure of culture supernatants from 188SLO(Y255A) to lyse
erythrocytes despite producing wild-type amounts of the variant SLO protein. Inset, corresponding Western blot for SLO in culture supernatants from
these strains. C. NADase activity in cell culture supernatants and in the cytosol of keratinocytes infected with GAS strain 771, 771SLO-,
771SLO(Y255A), or 771NADase-. Intracellular NADase activity due to translocation by extracellular GAS was identical between 771 and
771SLO(Y255A), but reduced in 771SLO-. D. The intracellular survival of 188SLO(Y255A) was significantly lower than that of its parental strain, 188,
and similar to that of 188SLO-. *, P,0.01. E. Confocal microscopy demonstrating the association between galectin 8 (green) and intracellular GAS
(red) in keratinocytes infected for 30 min with GAS strain 188, 188SLO-, or 188 SLO-SLS-. Extracellular GAS (GAS(out)) were stained blue and red for
identification as described in Figure 2. Scale bar = 10 mm. The percentage of intracellular GAS that were associated with galectin 8 is indicated for
each strain, based on quantification of at least 100 bacteria in three independent experiments. 188SLO-SLS- was never associated with galectin 8
(0%).
doi:10.1371/journal.ppat.1003394.g004
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but survived poorly. Furthermore, induction of xenophagy was not
required for efficient killing of SLO-negative GAS: a mutant
deficient in both SLO and SLS failed to induce xenophagy, but
was efficiently killed. Rather, production of SLO and the
associated co-toxin NADase appeared to be the critical events in
prolonged intracellular survival. The translocation of NADase into
keratinocytes has been shown previously to result in profound
depletion of intracellular NAD+ and ATP and to enhance SLO-
mediated cytotoxicity [27,29]. In the present study, we found that
SLO was required for prolonged GAS intracellular survival, both
for its ability to translocate NADase into the keratinocyte cytosol
and for its vacuolar membrane-damaging activity. NADase was
equally required for prolonged GAS survival, as mutants lacking
NADase or expressing an enzymatically inactive protein survived
poorly despite the membrane-damaging effects of SLO. Further
evidence for a key role for NADase came from experiments in
which the endogenous inhibitor of NADase was used to inhibit the
activity of the enzyme during intracellular infection. Inhibiting
NADase activity had a similar effect as inactivating the nga gene: it
markedly reduced GAS intracellular survival. By depleting cellular
energy stores, NADase may inhibit cellular repair of SLO damage
to the GAS-containing vacuole. Thus, the expression of both SLO
and NADase by wild-type GAS results in delayed and incomplete
fusion of LC3-positive GAS-containing vacuoles with lysosomes, a
pattern consistent with the observed prolonged survival of strains
that produce both toxins.
Our results suggest a model for GAS interaction with
oropharyngeal epithelial cells in which SLO and NADase are
central determinants of the fate of internalized bacteria (Figure 6).
Production of the pore-forming toxin SLO (and SLS) damages the
membrane of the bacterial vacuole, exposing GAS to the cytosol,
which triggers ubiquitin binding to the bacteria or to associated
damaged vacuolar membrane. Concurrently, damaged endosomal
membrane is recognized by cytosolic galectin 8. The process of
endosome disruption by either hemolysin stimulates formation of
an autophagosome-like compartment around the bacteria and/or
the damaged endosome. Since SLO and NADase are expressed
from the same operon, GAS that escape from endosomes via SLO
production presumably can secrete NADase directly into the
cytosolic milieu prior to capture by the host autophagic
machinery. Furthermore, SLO secreted by extracellular bacteria
bound to the epithelial cell surface mediates translocation of
NADase across the cell membrane into the keratinocyte cytosol. It
remains unclear whether NADase is translocated across endoso-
mal or autophagosomal membranes by SLO or by passive
diffusion through damaged compartment membranes, or if
sufficient amounts of enzyme are delivered to the cytosol by
SLO-mediated translocation from extracellular GAS. In either
case, once in the host cytosol, the enzymatic activity of NADase
inhibits or delays lysosomal fusion with GAS-containing autopha-
gosomes, an effect that promotes prolonged intracellular survival.
The fact that SLO-deficient GAS induced xenophagy but were
efficiently killed suggests that vacuolar membrane damage by SLS
is sufficient to induce xenophagy in the absence of SLO, but
insufficient to prevent rapid lysosomal fusion with the GAS-
containing vacuole. Ubiquitination of SLO-deficient GAS was also
drastically reduced compared to that of SLO-producing strains, an
observation that implies that SLS-mediated membrane injury by
itself is insufficient to allow bacterial access to the cytosol. These
observations suggest that SLO, through its potent endosomal
membrane-damaging activity and/or by translocating NADase,
plays a central role in intracellular survival that cannot be replaced
by SLS alone. Finally, blocking autophagy by knockdown of Beclin
1 failed to improve intracellular survival of SLO-deficient GAS, so
it appears that endosomes containing SLO-deficient GAS are able
to rapidly fuse with lysosomes for efficient bacterial killing even if
the autophagy pathway is blocked. In conclusion, xenophagy is
unnecessary for efficient killing of SLO-deficient GAS and
ineffective at killing wild-type GAS.
These findings reveal new insights into the complex molecular
dialog between GAS and the human host. Ingestion and killing by
pharyngeal epithelial cells appear to contribute to innate defense
against GAS infection. For organisms such as GAS that escape
from the canonical endocytic pathway, xenophagy represents an
alternative strategy of host cells to recapture these pathogens.
Although the SLO-mediated damage to the endosomal membrane
stimulates a xenophagic response, SLO also prevents functional
maturation of GAS-containing autophagosomes by direct injury to
the bacterial vacuole and by translocating NADase to the cytosol
where it inhibits lysosomal fusion. Together, these observations
uncover a novel mechanism for inhibition of xenophagic killing of
GAS and suggest that enhancement of intracellular survival
through the coordinated action of SLO and NADase contributes
to GAS persistence in the human pharynx.
Materials and Methods
Reagents
Unless otherwise indicated, reagents were purchased from
Sigma. Restriction endonucleases were from Thermo Scientific
and cell culture reagents were purchased from Life Technologies.
Antibodies to GAS group A carbohydrate, SLO, and NADase
have been described previously [29,42]. Mouse anti-LAMP-1
(CD107a) was from BD Biosciences (555798); mouse anti-
ubiquitin (clone FK2) was from Enzo Life Sciences; anti-galectin
8 affinity-purified goat polyclonal IgG (AF1305) was from R&D
Systems; rabbit anti-Beclin 1 antibody (NB500-249) was from
Novus Biologicals. Unconjugated and fluorescent secondary
antibodies were from Santa Cruz and Molecular Probes,
respectively. Fluorescent dyes were purchased from Molecular
Probes. siRNA reagents were from Dharmacon (Lafayette, CO).
Bacterial strains and culture conditions
GAS strains used in this study are listed in Table S1. GAS strain
188 is an isogenic unencapsulated mutant of the M type 3
necrotizing fasciitis isolate 950771 [33]. Use of an unencapsulated
mutant results in efficient internalization of GAS by human cells in
vitro because internalization is inhibited by the hyaluronic acid
capsule [9]. GAS strains JRS4, JRS4SLO-, and JRS4NADase-
were provided by M. Caparon [28,43,44]. Escherichia coli DH5a
was used as a host for molecular cloning (Zymo Research) and was
grown in Luria-Bertani (LB) medium (Novagen). GAS were
routinely grown in L3 medium with two modifications [45]: the
final CaCl2 concentration was 0.015% and type 1-S bovine
Figure 5. SLO and NADase inhibit lysosomal fusion to GAS-containing autophagosomes in oropharyngeal keratinocytes. A. Confocal
microscopy of keratinocytes infected with GAS strain 188, 188SLO-, or 188NADase- demonstrating the association of the lysosomal marker LAMP-1
(red) with GAS (blue) contained within EGFP-LC3 (green)-positive compartments at 1 h, 3 h, and 6 h post-infection. Scale bar = 10 mm. B.
Quantification of the percent of GAS within EGFP-LC3-positive compartments that are co-localized with LAMP-1 at 1 h, 3 h, and 6 h. Data represent
mean values from three independent experiments in which at least 100 intracellular GAS were quantified for each time point in each experiment.
doi:10.1371/journal.ppat.1003394.g005
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hyaluronidase was omitted. When appropriate, antibiotics were
used at the following concentrations: ampicillin at 100 mg/ml,
penicillin at 20 mg/ml or 1 mg/ml, spectinomycin at 50 mg/ml,
gentamicin at 200 mg/ml, and erythromycin at 200 mg/ml or
1 mg/ml for E. coli or GAS, respectively.
DNA manipulations
Oligonucleotide primers are listed in Table S2. To generate the
substitutions Y255A in SLO and G330D in NADase, the codons
encoding the relevant residues were mutated by overlap extension
PCR. Briefly, using GAS 188 genomic DNA as a template,
overlapping oligonucleotides containing the desired mutation
(sloY255AF and sloY255AR or ngaG330DF and ngaG330DR)
were used in separate PCR reactions with an upstream and
downstream primer (slo_up and slo_down or nga_up and
nga_down) to generate two PCR products that overlap in the
region containing the mutation. This was followed by a second
PCR amplification using the external ‘up’ and ‘down’ oligonucle-
otide primers, using the product of the first PCR as a template, to
generate a single recombinant DNA fragment of 1.5 kb
(SLO(Y255A)) or 1.3 kb (NADase(G330D)). The external oligo-
nucleotides also contained restriction endonuclease sites (BamHI
and SalI) that facilitated directional cloning into the streptococcal
shuttle vector, pJRS233 [46]. DNA inserts were verified by DNA
sequencing (Genewiz). The recombinant shuttle plasmids were
then introduced into GAS strain 188 or 771 by electroporation,
and mutant alleles were exchanged for the native chromosomal
loci by allelic exchange as described previously [33]. Strain
188SLO-SLS- was constructed by allelic exchange of an
internally-deleted sagA sequence in strain 188SLO- as described
previously [47]. Mutant strains were verified by DNA sequencing
of the relevant locus (Genewiz).
Figure 6. Model of the intracellular fate of GAS in oropharyngeal keratinocytes. Shortly after internalization, GAS are associated with early
endosomes. Within minutes, however, damage to the endosomal membrane by the action of SLO and SLS exposes glycans that bind the cytosolic
lectin, galectin 8. In addition, SLO produces sufficient damage to the GAS-containing endosome that the bacteria become ubiquitinated upon
exposure to the cytosol. Ubiquitin and/or galectin 8 target cytosolic bacteria and damaged endosomes for incorporation into autophagosome-like
compartments, which eventually fuse with lysosomes. Lysosomal fusion is delayed or inhibited by SLO pore-formation and SLO-mediated delivery of
NADase into the cell cytosol, thus prolonging GAS intracellular survival.
doi:10.1371/journal.ppat.1003394.g006
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To generate pSEC-IFS, two recombinant DNA fragments were
cloned in the streptococcal plasmid pDL278 [48] into which the
constitutive guaB promoter had already been inserted (pDL278-
PguaB, a gift from Ioannis Gryllos). The first fragment was
amplified from a genomic DNA preparation of strain 188 using
the primer pairs SigF and SigR (see Table S1) and comprised the
region encoding the signal sequence of SLO. This fragment
contained a 39 BamHI site to facilitate ligation to a 59 BamHI site
within the second PCR fragment, which encoded a FLAG tag
linked to ifs, generated by PCR using 188 genomic DNA as
template and the primers ifsF and ifsR (Table S1).
To generate pBabe/EGFP-LC3, the AgeI-SalI fragment from
pEGFP-LC3 (Addgene plasmid 11546) was ligated into pBabe-
puro (Addgene plasmid 1764) that had been digested with NgoMIV
and SalI, which produce compatible ends.
RNAi was performed according to the manufacturer’s instruc-
tions (Dharmacon), and knock-down of Beclin 1 was confirmed by
western blot.
Cell culture
OKP7/bmi1/TERT (OKP7) immortalized primary human soft-
palate keratinocytes were a gift of James Rheinwald and were provided
through the Harvard Skin Disease Research Center [49]. Keratino-
cytes were cultured in serum-free keratinocyte medium (KSFM, Life
Technologies) supplemented with 50 mg ml21 bovine pituitary extract,
0.1 ng ml21 epidermal growth factor and 0.3 mM calcium chloride.
Other cell lines were grown in DMEM containing 10% fetal bovine
serum. HeLa cells (ATCC) were transfected with plasmid EGFP-LC3
encoding a fusion protein of human LC3 with EGFP. Cells were
transfected by incubation with pEGFP-LC3 and Lipofectamine 2000
(Life Technologies) for 6 hours in Opti-MEM (Life Technologies).
Transient expression of EGFP-LC3 in OKP7 cells was achieved by
retroviral transduction with viral particles produced by the transfection
of HEK293T cells with pBabe/EGFP-LC3 and a three plasmid
retroviral system as previously described [50].
Intracellular survival assay
OKP7 cells were infected at a multiplicity of infection (MOI) of
10 with GAS that had been grown to mid-exponential phase and
washed twice in KSFM. Infected cell monolayers were treated with
20 mg/ml penicillin G and 200 mg/ml gentamicin or without
antibiotic for 45 minutes beginning 1 h 15 min post infection in
order to determine the internalized and total associated GAS,
respectively, at 2 h post infection. At 2 h post infection, intracellular
and cell-associated bacteria were quantified as described previously
[15]. Supernatant samples were also collected to determine the cell
cytotoxicity due to GAS by measurement of lactate dehydrogenase
(LDH) release (Roche). To determine intracellular survival, infected
monolayers that had been treated with antibiotics were washed at
2 h post infection and replenished with fresh medium containing
penicillin G (1 mg/ml). The infected monolayers were incubated for
4 h, 6 h, 8 h or 24 h post infection, at which times the total
intracellular CFU were determined as above. For assays involving
GAS strains harboring a plasmid, bacterial cultures were grown in
the presence of antibiotic, and subsequent infections were
performed in the absence of selection. Replica plating from the
bacterial output plates onto antibiotic-containing medium con-
firmed plasmid maintenance during the assay. Intracellular survival
assays using the inducible SLO (iSLO) complementation system
were performed in the presence of 1 mM IPTG.
Confocal microscopy
OKP7 cells were infected with GAS as described above.
Antibiotics were omitted to avoid uptake and analysis of dead
bacteria. For end points later than 2 h, cells were washed at 2 h
post infection in PBS, and fresh KSFM was added for further
incubation. At the end of each incubation, monolayers were
washed with PBS and, when appropriate, extracellular GAS were
stained with Alexa Fluor 660-conjugated anti-GAS IgG at 4uC for
15 min. Samples were then fixed and permeabilized by incubation
in ice-cold methanol at 220uC for 5–10 minutes. Cells were then
washed in PBS and incubated with the appropriate primary and
secondary antibodies at room temperature in the dark for 1 h.
Slides were mounted using Prolong Gold (Molecular Probes) and
stored for 16–24 h at room temperature in the dark prior to
imaging. Confocal microscopy was performed at the Harvard
Digestive Diseases Center core facility as previously described
[15]. Images were acquired and analyzed using Slidebook 5
(Intelligent Imaging Innovations, Denver, CO). For quantification,
bacterial co-localization with endosomal markers was determined
from three independent experiments, and at least 100 intracellular
bacteria were counted for each experiment.
Electron microscopy
OKP7 cells were infected for 3 h as described above (Confocal
microscopy), immersed in fixative solution (0.1 M sodium
cacodylate, 2% paraformaldehyde, 2.5% gluteraldehyde) for
30 min at room temperature, and then processed and imaged at
the Electron Microscopy Core facility at Beth Israel Deaconess
Medical Center (http://www.bidmc.org/Research/Core-
Facilities/Electron-Microscopy-Core.aspx).
Measurement of SLO and NADase activity
SLO activity was measured by determination of the hemolytic
titers of culture supernatants from liquid cultures of GAS taken at
early stationary phase, as described previously (Ruiz et al. 1998).
NADase activities of bacterial culture supernatants and of the
cytosolic fraction of eukaryotic cells exposed to GAS were
determined as described previously [27].
Statistical analysis
Statistical significance of differences between experimental
conditions was determined by Student’s t-test. P values of less
than 0.05 were considered significant and are indicated by an
asterisk (*) in figures.
Supporting Information
Figure S1 Intracellular survival of GAS in HeLa cells
and cytotoxic effects of GAS on HeLa and OKP7 cells. A.
Intracellular survival in HeLa was determined as described above
for strains 188 and 188SLO- (SLO-). Data represent mean6SD of
three independent experiments. *, P,0.001. B. LDH release was
measured at 2 h post-infection to determine cytotoxicity to HeLa
cells due to GAS. C. LDH release from OKP7 cells infected with
188 and 188SLO- at 2 h, 6 h, 12 h and 24 h post-infection.
Intracellular survival results were not considered reliable when
LDH release exceeded 5% at 2 h post-infection (i.e., for HeLa cells
infected with strain 188).
(PDF)
Figure S2 Induction of autophagy in OKP7 cells by GAS
or purified recombinant SLO. A. GAS strain JRS4 and
JRS4SLO- enter autophagosome-like compartments in OKP7
oropharyngeal keratinocytes. B. In HeLa cells, GAS localization
to autophagosomes is SLO-dependent. HeLa cells stably express-
ing EGFP-LC3 were exposed to GAS strains 188 or 188SLO-
(SLO-), and the association between EGFP-LC3 and GAS was
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assessed by confocal microscopy at 3 h post-infection as described
above. Scale bar = 10 mm. C. Exposure of OKP7 cells to GAS
strains that produce SLO (188, SLO-, NADase-, and SLS-) is
associated with an increase in LC3-II. Left, lysates of uninfected
cells or cells exposed to GAS strains for 2 h were probed with LC3
antibody. Right, cells were incubated with various amounts of
recombinant SLO. An increase in the ratio of LC3-II:LC3-I
indicates increased autophagosome formation.
(PDF)
Figure S3 siRNA knockdown of becn1 (Beclin 1). Lysates
from OKP7 cells treated with non-targeting siRNA (non-target) or
an siRNA pool directed against Beclin 1 (becn1) were analyzed by
Western blot for Beclin 1 production. GAPDH was used as a
loading control.
(PDF)
Figure S4 A GAS strain engineered to secrete the
endogenous NADase inhibitor IFS exhibits impaired
intracellular survival. A. Intracellular survival of strain 188
expressing a secreted FLAG-tagged GAS NADase inhibitor IFS
from an expression vector (188(pSEC-IFS)) or strain 188 or
188NADase- carrying empty vector (188(pDL278) or NADase-
(pDL278), respectively). *, P,0.001. Data represent the
mean6SD of three independent experiments. B. Quantification
of NADase activity in culture supernatants from GAS strains
188(pDL278), NADase-(pDL278), and 188(pSEC-IFS). C. West-
ern blot for NADase and FLAG of culture supernatants described
in (B). Expression and secretion of FLAG-tagged IFS (strain
188(pSEC-IFS)) eliminated extracellular NADase activity by GAS
strain 188 despite the presence of wild type levels of NADase
secretion by Western blot.
(PDF)
Table S1 GAS strains used in this study.
(PDF)
Table S2 Oligonucleotide primers used in this study.
(PDF)
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